It has been reported that the expression of either LPCAT1 or ENPP2 is increased and some LPCs are decreased in diverse human tumors including hepatoma [22], melanoma [23], and acute myeloid leukemia [24]. The gene discussed is ENPP2; the disease is hepatocellular carcinoma.